ANRO
insider transactionsAlto Neuroscience, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
26.0K sh
Own New
-
Other·G
Amit Etkin KEY
PRESIDENT AND CEO
$0
400.0K sh
Own -32%
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Grant·A
Director
$0
11.0K sh
Own New
-
Other·F
CHIEF FINANCIAL OFFICER & CBO
$55.3K
2.8K sh · $19.69
Own -10%
-
Other·F
Amit Etkin KEY
PRESIDENT AND CEO
$122.6K
6.2K sh · $19.69
Own -1%
-
Grant·A
CHIEF FINANCIAL OFFICER & CBO
$0
200.0K sh
Own New
-
Grant·A
CHIEF MEDICAL OFFICER
$0
124.0K sh
Own New
-
Grant·A
Amit Etkin KEY
PRESIDENT AND CEO
$0
306.0K sh
Own New
-
Grant·A
CHIEF OPERATING OFFICER
$0
131.0K sh
Own New
-
Grant·A
Director
$50.0K
4.2K sh · $11.82
Own New
-
Grant·A
Director
$62.0K
5.2K sh · $11.82
Own New
-
Grant·A
Director
$85.0K
7.2K sh · $11.82
Own New
-
Grant·A
Director
$45.0K
3.8K sh · $11.82
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 27, 2026 | Andrew Craig Miller | Grant A | 26.0K | $0 |
| May 14, 2026 | Amit Etkin KEY | Other G | 400.0K | $0 |
| May 12, 2026 | Husseini Manji | Grant A | 11.0K | $0 |
| May 12, 2026 | Gwill York | Grant A | 11.0K | $0 |
| May 12, 2026 | Christopher Nixon Cox | Grant A | 11.0K | $0 |
| May 12, 2026 | Ramiro Sanchez | Grant A | 11.0K | $0 |
| May 12, 2026 | Andrew Dreyfus | Grant A | 11.0K | $0 |
| Mar 1, 2026 | Nicholas Conrad Smith KEY | Other F | 2.8K | $55.3K |
| Mar 1, 2026 | Amit Etkin KEY | Other F | 6.2K | $122.6K |
| Feb 11, 2026 | Nicholas Conrad Smith KEY | Grant A | 200.0K | $0 |
| Feb 11, 2026 | Adam Savitz | Grant A | 124.0K | $0 |
| Feb 11, 2026 | Amit Etkin KEY | Grant A | 306.0K | $0 |
| Feb 11, 2026 | Michael Conick Hanley Jr. | Grant A | 131.0K | $0 |
| Jan 2, 2026 | Husseini Manji | Grant A | 4.2K | $50.0K |
| Jan 2, 2026 | Gwill York | Grant A | 5.2K | $62.0K |
| Jan 2, 2026 | Christopher Nixon Cox | Grant A | 7.2K | $85.0K |
| Jan 2, 2026 | Ramiro Sanchez | Grant A | 3.8K | $45.0K |
About ANRO insider trading
This page tracks insider transactions for Alto Neuroscience, Inc. (ANRO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.